Platelet Analysis by Flow Cytometry;Durchfluϐzytometrische Analyse von Thrombozyten

LaboratoriumsMedizin

Volumn 25, Issue 11-12, 2001, Pages 533-540

  Barlage, S ^a   Rothe, G ^a   Schmitz, G ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

activation; Aktivierung; DurchfluBzytometrie; flow cytometry; platelet count; platelets; thrombocytopenia; Thrombozyten; Thrombozytenzahl; Thrombozytopenie

Indexed keywords

THROMBOCYTE ANTIBODY;

FLOW CYTOMETRY; PHENOTYPE; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE ANOMALY; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPOIESIS;

EID: 0035671079     PISSN: 03423026     EISSN: 14390477     Source Type: Journal    
DOI: 10.1515/labm.2001.25.11-12.533     Document Type: Article

References (72)

1. Rao, GHR. Platelet physiology and pharmacology: an overview. In: Handbook of platelet physiology and pharmacology Norwell. Massachusetts (USA): Kluwer Academic Publishers, 1999:1–20.
2. George, JN. Platelets. Lancet 2000:355:1531-9.
3. Kabbani, SS, Watkins, MW, Ashikaga, T., Terrien, EF, Holoch, PA, Sobel, BE, Schneider, DJ. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 2001;104:181-6.
4. Schmitz, G., Rothe, G., Ruf, A., Barlage, S., Tschope, D., Clemetson, KJ, Goodall, AH, Michelson, AD, Nurden, AT, Shankey, TV. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998;79:885-6.
5. Harrison, P. Ault, KA, Chapman, S., Charie, L., Davis, B., Fujimoto, K., Houwen, B., Kunicka, J., Lacombe, F., Machin, S., Raynor, R. van Hove, L., van Assendelft, OW. An interlaboratory study of a candidate reference method for platelet counting. Am J Clin Pathol 2001:115:448-59.
6. Nieuwenhuis, HK, van Oosterhout, JJ, Rozemuller, E., van Iwaar-den, F., Sixma, JJ. Studies with a monoclonal antibody against activated platelets: evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987;70:838-45.
7. Stenberg, PE, McEver, RP, Shuman, MA. Jacques, YV, Bainton, DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985:101:880-6.
8. Michelson, AD, Barnard, MR. Hechtman, HB, MacGregor, H. Connolly, RJ. Loscaizo, J., Valeri, CR. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996:93:11877-82
9. Escolar, G., White, JO. Changes in glycoprotein expression after platelet activation: differences between in vitro and in vivo studies. Thromb Haemost 2000;83:371-86.
10. Sims, PJ. Ginsberg, MH. Plow, EF, Shattil, SJ. Effect of platelet activation on the conformation of the plasma membrane glycoprotein llb-lila complex. J Biol Chem 1991;266:7345-52.
11. Otooie, TE, Loftus, JC. Du, XP, Glass, AA, Ruggeri, ZM, Shattil, SJ, Plow, EF. Ginsberg, MH. Affmity modulation of the alpha lib beta 3 integrin (platelet GPlIb-IlIa) is an intrinsic property of the receptor. Cell Regul 1990; 1:883-93.
12. Nurden, P. Humbert, M. Piotrowicz, RS, Bihour, C, Poujol, C, Nurden, AT, Kunicki, TJ. Distribution of ligand-occupied alpha lib beta 3 in resting and activated human platelets determined by expression of a novel class of ligand-induced binding site recognized by monoclonal antibodv AP6. Blood 1996;88:887–99.
13. Mondoro, TH. Wall, CD. White, MM. Jennings, LK. Selective induction of a glycoprotein Ilia ligand-induced binding site by fibrinogen and von Willebrand factor. Blood 1996:88:3824-30.
14. Becker, RC. Tracy, RP. Bovill, EG. Mann, KG, Ault, K. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMl-lU Thrombosis and Anticoagulation Group. Coron Artery Dis 1994:5:339-45.
15. Mathur, A, Robinson, MS. Cotton, J. Martin, JF, Erusalimsky, JD. Platelet reactivity in acute coronary' syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thromb Haemost 2001;85:989-94.
16. Peter, K, Kohler, B, Straub, A. Ruef, J, Moser, M, Nordt, T, Olschewski, M, Ohman, ME. Kublcr, W, Bode, C. Flow cytometric monitoring of glycoprotein llb/llla blockade and platelet function in patients with acute myocardial intarctiou receiving reteplase, abciximab. and ticlopidine: coiitiiuious platelet inhibition by the combination of abciximab and ticlopidinc. Circulation 2000; 102:1490-6.
17. Minamino, T, Kitakaze, M. Sanada, S, Asanuama, H, Kurotobi, T, Korctsune, Y. Fukunami, M. Kuzuya, T. Hoki, N, Hori, M. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. Circulation 1998:98:1721-7.
18. Tschoepe, D, Schultheiss, HP. Kolarov, P, Schwippert, B, Dannehl, K, Nieuwenhuis, HK Kehrel, B, Strauer, B, Gries, FA. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993:88:37–42.
19. Scharf, RE. Tomer, A. Marzec, UM. Teirstein, PS, Ruggeri, ZM. Harker, LA. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection. Arterioscler Thromb 1992; 12:1475-87.
20. Kabbani, SS, Watkins, MW. Ashikaga, T, Terrien, EF, Holoch, PA, Sobel, BE. Schneider, DJ. Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention. Circulation 2001:104:181-6.
21. Peter, K, Kohler, B, Straub, A. Ruef, J, Moser, M, Nordt, T, Olschewski, M. Ohman, ME. Kubler, W, Bode, C. Flow cytometric monitoring of glycoprotein llb/llla blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine. Circulation 2000;102:1490-6.
22. May, AE, Neumann, FJ. Gawaz, M. Ott, I, Walter, H, Schomig, A. Reduction of monocvte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation. Eur Heart J 1997;18:1913-20.
23. Tcheng, JE, Ellis, SG. Georsie, BS. Kereiakes, DJ, Kleiman, NS. Talley, JD, Wang, AL, Weisman, HF. Califf, RM, Topol, EJ. Pharma-codvnamics of chimeric glycoprotein Ilb/IIIa integrin antiplatelet antibody Fab 7E3 in hish-nsk coronary angioplasty. Circulation 1994:90:1757-64.
24. Jennings, LK. Dockter, ME. Wall, CD. Fox, CF, Kennedy, DM. Calcium mobilization in human platelets using indo-1 and flow cytometry. Blood 1989:74:2674-80.
25. Tschoepe, D, Spangenbera, R Esser, J, Schwippert, B. Kehrel, B, Roesen, R Gries, FA. Flow-cytometric detection of surface menri-brane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry 1990:11:652-6.
26. Ruf, A, Patscheke, H. Flow cytometric detection of activated platelets: comparison of detemiining shape change, fibrinogen binding, and P-selectin expression. Semin TTriromb Hemost 1995;21:146-51.
27. Li, N, Goodall, AH, Hjemdahl, P. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. Cytometry 1999:35:154-61.
28. Furman, Ml, Barnard, MR, Krueger, LA, Fox, ML Shilale, EA, Lessard, DM, Marchese, P, Frelinger, AL, Goldberg, RJ, Michelson, AD. Circulating monocyte-platelet of acute myocardial infarction. J Am Coll Cardiol 2001.38.1002-6.
29. Michelson, AD. Barnard, MR, Krueger, LA, Valeri, CR, Furman, ML Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104:533-7.
30. Furman, Ml, Benoit, SE, Barnard, MR, Valeri, CR. Borbone, ML. Becker, RC, Hechtman, HB, Michelson, AD. Increased platelet reactivity and circulating monocyte-platelet stable coronary artery disease. J Am Coll Cardiol 1998;31;352-8
31. Gawaz, M, Dickfeld, T. Bogner, C, Fateh-Moghadam, S, Neumann, FJ. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med 1997;23:379-85.
32. Neumann, FJ, Marx, N. Gawaz, M, Brand, K. Ott, I, Rokiita, C. Sticherling, C, MeinI, C. May, A. Schomig, A. Induction of cytokine expression in leukocytes by binding of thronibin-siimulaied platelets. Circulation 1997;95:2387-94.
33. Amirkhosravi, A, Alexander, M, May, K, Francis, DA, Wames, G, Biggerstaff, J, Francis, JL. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thromb Haemost 1996;75:87–95.
34. Abrams, CS, Ellison, N, Budzynski, AZ. Shaitil, SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990:75:128-38.
35. Pasquet, JM, Toti, F, Nurden, AT. Dachary-Prigent, J. Procoagulant activity and active calpain in platelet-derived niicroparticfes. Thromb Res 1996;82:509-22.
36. Nieuwland, R. Berckmans, RJ, Rotteveel-Eijkman, RC. Maquelin, KN, Roozendaal, KJ, Jansen, PG. ten Have, K. Eijsman, L. Hack, CE. Sturk, A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoaaulant. Circulation 1997;96:3534-41.
37. Gilbert, GE, Sims, PJ, Wiedmer, T, Furie, B. Furie, BC. Shattil, SJ. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 1991:266:17261-8.
38. Wiedmer, T, Shattil, SJ, Cunningham, M, Sims, PJ. Role of calcium and calpain in complement-induced vésiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990:29:623-32.
39. Singh, N, Gemmell, CH. Daly, PA, Yeo, EL. Elevated platelet-derived microparticle levels during unstable angina. Can J Cardiol 1995:11:1015-21.
40. Zeiger, F, Stephan, S, Hoheisel, G. Pfeiffer, D. Ruehlmaim, C. Koksch, M. P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial di.sease. Blood Coagul Fibrinolysis 2000; 11:723-8.
41. Nieuwland, R, Berckmans, RJ. McGregor, S. Boing, AN. Romijn, FP, Westendorp, RG, Hack, CE. Sturk, A, Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000:95:930-5.
42. Ogura, H. Kawasaki, T, Tanaka, H. Koh, T. Tanaka, R, Ozeki, Y. Hosotsubo, H, Kuwagata, Y, Shimazu, T. Sugimoto, H. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and.sepsis. J Trauma 2001;.50:801-9.
43. Jy, W, Horstman, LL, Arce, M, Ahn, YS. Clinical signincanoe of platelet microparticles in autoimmune thrombocvtopenias. J Lab Clin Med 1992:119:334-45.
44. Warkentin, TE, Fowling, MJ, Hardisty, RM. Measurement of fibrinogen binding to platelets in whole blood by How cytometry; a micromethod for the detection of platelet activation. Br J Haematol 1990:76:387-94.
45. Fabris, F, Casonato, A, Randi, ML, Luzzaito, G, De Silvestre, G. Ongaro, G, Girolami, A. The use of tluore.scence flow cytometry in the characterization of Bemard-Soulier syndrome and Glanzmann's thrombasthenia. Haematologica 1989:74:39–44.
46. Sharp, WJ. Khanduri, UD, Christiem, BS. Rapid heterozygote detection in Glanzmann's thrombasthenia. Br J Haematol 1998;101:66-9.
47. Wall, JE, Buijs-Wilts, M, Arnold, JT. Wang, W. White, MM. Jennings, LK, Jackson, CW. A flow cytometric assay using mepacrine for studv of uptake and release of platelet dense granule contents. Br J Haematol 1995;89:380-5.
48. Gordon, N, Thom, J, Cole, C. Baker, R. Rapid detection of hered-itar)' and acquired platelet storage pool deficiency by flow cytometry. Br J Haematol 1995;89:117-23.
49. Gawaz, MP, Bogner, C, Gurland, HJ. Flow-cytometric analysis of mepacrine-labelled.platelets in patients with end-stage renal failure. Haemostasis 1993:23:284-92.
50. Lages, B, Shattil, SJ, Bainton, DF, Weiss, HJ. Decreased content and surface expression of alpha-granule membrane protein GMP-140 in one of two types of platelet alpha delta storage pool deficiency. J Clin Invest 1991:87:919-29.
51. Sims, PJ, Wiedmer, T, Esmon, CT, Weiss, HJ, Shattil, SJ. Abiembly of the platelet prothrombinase complex is linked to vésiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989:264:17049-57.
52. Kienast, J. Schmitz, G. Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 1990;75:116-21.
53. Ault, KA, Knowles, C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 1995:23:996–1001.
54. Rinder, HM, Munz, UJ, Ault, KA, Bonan, JL, Smith, BR. Reticulated platelets in the evaluation of thrombopoietic disorders. Arch Pathol Lab Med 1993:117: 606-10.
55. Ault, KA, Rinder, HM, Mitchell, J, Carmody, MB, Vary, CP. Hillman, RS. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 1992;98:637-46.
56. Consolini, R, Calleri, A, Bengala, C. Legitimo, A. Conte, PF, Evaluation of thrombopoiesis kinetics by measurement of reticulated platelets and CD34-I-cell subsets in patients with solid tumors following high dose chemotherapy and autologous peripheral blood progenitor cell support. Haematologica 2001;86;959-64.
57. Romp, KG, Peters, WP. Hoffman, M. Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in as.sessing marrow recovery. Am J Hematol 1994:46:319-24.
58. Stohlawett, P, Stiegler, G, KnobI, P. Hocker, P. Panzer, S. The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions. Ann Hematol 1999:78:271-3.
59. Richards, EM, Jestice, HK. Mahendra, P. Scott, MA. Marcus, RE. Baglin, TP Measurement of reticulated platelets following peripheral blood progenitor cell and bone marrow transplantation: implications for marrow reconstitution and the use of thrombopoietin. Bone Marrow Tran.splant 1996:17:1029-33.
60. Matic, GB. Chapman, ES, Zaiss, M. Rothe, G. Schmit, G. Whole blood analysis of reticulated platelets: improvements of detection and assay stability. Cytometry 1998;34:229-34.
61. Stockelberg, D. Hou, M. Jacobsson, S. Kutti, J. Wadenvik, II. Detection of platelet antibodies in chronic idiopathic thrombocytopenic purpura (ITP). A comparative study using How cytomctry. a whole platelet ELISA, and an antigen capturo ELISA. fur J Haematol 1996:56:72-7.
62. Janisiw, M. Eichelberger, B. Koren, D. Paner, S. Screening for platelet auto-antibodies by How cytometry and their evaluation by the MAIPA technique. Wien Klin wochcn.schr 1998;110:531-4.
63. Hagenstrom, H. Schlenke, P. Hennig, H. Kirchner, II. Kluter, II. Quantification of platelet-as.sociatod IgG for differential diagnosis of patients with thrombocytopenia. Thromb Haemosi 2000:84:779-83
64. Koksch, M. Rothe, G. Kiefel, V, Schmitz, G. Fluorescence rcstnance energy transfer as a new method for the epitope-speciUc characterization of anti-platelet antibodies. J Immunol Methods 1995:187:53–67.
65. Poley, S. Mempel, W. Laboratory diagnosis of heparin-induced thrombocytopenia: advantages of a functional How cytt)mciric test in comparison to the heparin-induced platelet-activation test. Eur J Haematol 2001:66:253-62.
66. Jy, W, Mao, WW. Horstman, LL, Valant, Paahn, YS. A Ilow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocvtopenia (HIT) from HIT with thrombosis (HITT). Thromb Haemosi 1999:82:1255-9.
67. Joseph, JE, Harrison, P. Mackie, IJ. Machin, SJ. Platelet activation markers and the primary antiphospholipid.syndrome (PAPS). Lupus 1998:7 Suppl 2:S48-51.
68. Lackner, KJ, von Landenberg, C, Bariage, S. Schmitz, G. Analysis of prolhrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Thromb Haemost 2000;83:583-8.
69. Ford, I, Urbaniak, S, Greaves, M. IgG from patients with antiphospholipid syndrome binds to platelets without induction of platelet activation. Br J Haematol 1998;102:841-9.
70. Harrison, P. Ault, KA, Chapman, S, Charie, L, Davis, B, Fujimoto, K. Houwen, B. Kunicka, J, Lacombe, F, Machin, S, Raynor, R, van Hove, L, van Assendelft, OW. An interiaboratory study of a candidate reference method for platelet counting. Am J Clin Pathol 2001:115:448-59.
71. Kunz, D, Hofflces, H, Kunz, WS. Gressner, AM. Standardized flow cytometric method for the accurate determination of platelet counts in patients with severe thrombocytopenia. Cytometry 2000;42:284-9.
72. Harrison, P. Horton, A, Grant, D, Briggs, C, MacHin, S. Immuno-platelet counting: a proposed new reference procedure. Br J Haematol 2000:108:228-35.